The purpose of mixing studies in prolonged aPTT?

• A. To differentiate factor deficiency from an inhibitor
• B. To determine vitamin K status
• C. To measure fibrinogen levels
• D. To assess intrinsic pathway directly

Answer: (A)

The main idea is that mixing studies help you tell whether a prolonged aPTT is due to missing clotting factors or to an inhibitor that blocks those factors. When patient plasma is mixed 1:1 with normal plasma, the normal plasma supplies the factors that may be deficient. If the aPTT returns to normal, it means the problem was a factor deficiency in the patient’s intrinsic pathway factors (the added factors from the normal plasma fixed the issue). If the aPTT stays prolonged after mixing, it suggests an inhibitor is present in the patient’s plasma that continues to interfere with clotting even when normal factors are added (for example, a factor VIII inhibitor or a lupus anticoagulant). Sometimes the result can depend on incubation time, revealing time‑dependent inhibitors, but the key takeaway is: correction with mixing points to deficiency; no correction points to an inhibitor. Vitamin K status and fibrinogen levels are determined by other tests, and while the aPTT assesses the intrinsic pathway, the mixing study specifically distinguishes deficiency from inhibition.